These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9108959)

  • 1. Potential role for granulocyte-macrophage colony-stimulating factor in the treatment of HIV-associated cryptococcal meningitis.
    Price DA; Klein JL; Fisher M; Main J; Bingham JS; Coker RJ
    AIDS; 1997 Apr; 11(5):693-4. PubMed ID: 9108959
    [No Abstract]   [Full Text] [Related]  

  • 2. Recurrence of cryptococcal meningitis in HIV-infected patients following immune reconstitution.
    Seddon J; Mangeya N; Miller RF; Corbett EL; Ferrand RA
    Int J STD AIDS; 2009 Apr; 20(4):274-5. PubMed ID: 19304977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cryptococcal meningitis in an immunocompetent patient: efficacy of fluconazole].
    MĂ­nguez Castellanos A; Ortega Moreno A; Vilches Carrillo RM; Foronda Bengoa J
    Neurologia; 1992 Nov; 7(9):276-8. PubMed ID: 1445716
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV-related immune reconstitution cryptococcal meningoradiculitis: corticosteroid response.
    Brunel AS; Makinson A; de Champfleur NM; Thouvenot E; Le Moing V; Lefalher G; Bonafé A; Reynes J
    Neurology; 2009 Nov; 73(20):1705-7. PubMed ID: 19917995
    [No Abstract]   [Full Text] [Related]  

  • 5. Maintenance therapy with itraconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome.
    Chotmongkol V; Sukeepaisarncharoen W
    J Med Assoc Thai; 1997 Dec; 80(12):767-70. PubMed ID: 9470329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of adjuvant granulocyte-macrophage colony-stimulating factor in HIV-related disseminated atypical mycobacterial infection.
    de Silva TI; Cope A; Goepel J; Greig JM
    J Infect; 2007 Apr; 54(4):e207-10. PubMed ID: 17197031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
    Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K
    J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of cryptococcal meningitis.
    Zingman BS
    N Engl J Med; 1997 Nov; 337(21):1557; author reply 1557-8. PubMed ID: 9380128
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and adverse effects of higher dose amphotericin B monotherapy for cryptococcal meningitis in patients with advanced HIV infection.
    Hsieh SM; Hung CC; Chen MY; Hsueh PR; Chang SC
    J Microbiol Immunol Infect; 1998 Dec; 31(4):233-9. PubMed ID: 10496164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus (HIV) related cryptococcal meningitis in rural central Thailand--treatment difficulties and prevention strategies.
    Wright P; Inverarity D
    Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):58-61. PubMed ID: 17539247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral thrombophlebitis as a paradoxical reaction in HIV-patients.
    Prendki V; Dumas JL; Bouges-Michel C; Boch AL; Bouchaud O; Abgrall S
    AIDS; 2008 Jul; 22(11):1384-5. PubMed ID: 18580625
    [No Abstract]   [Full Text] [Related]  

  • 12. A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B.
    Pitisuttithum P; Tansuphasawadikul S; Simpson AJ; Howe PA; White NJ
    J Infect; 2001 Nov; 43(4):226-33. PubMed ID: 11869059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial treatment with amphotericin B plus rifampin in the acute treatment of cryptococcal meningitis in aids.
    Chotmongkol V; Methawasin K
    Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):776-8. PubMed ID: 12041553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis.
    Pappas PG; Bustamante B; Ticona E; Hamill RJ; Johnson PC; Reboli A; Aberg J; Hasbun R; Hsu HH
    J Infect Dis; 2004 Jun; 189(12):2185-91. PubMed ID: 15181565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial commentary: dosing amphotericin B in cryptococcal meningitis.
    Powderly WG
    Clin Infect Dis; 2008 Jul; 47(1):131-2. PubMed ID: 18505386
    [No Abstract]   [Full Text] [Related]  

  • 16. Ethical considerations in the care of the patient with HIV/AIDS.
    Gangaidzo IT; Mielke J; Matenga JA
    Cent Afr J Med; 1999 Feb; 45(2):51-3. PubMed ID: 10444904
    [No Abstract]   [Full Text] [Related]  

  • 17. Initial treatment of cryptococcal meningitis in AIDS.
    Chotmongkol V; Arayawichanont A; Sawanyawisuth K; Thavornpitak Y
    Southeast Asian J Trop Med Public Health; 2005 Jan; 36(1):170-3. PubMed ID: 15906662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal treatment for cryptococcal meningitis.
    Powderly WG
    Intern Med J; 2006 Jul; 36(7):404-5. PubMed ID: 16780444
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of cryptococcal meningitis in AIDS: the need for specific studies in developing countries.
    Lortholary O
    Clin Infect Dis; 2007 Jul; 45(1):81-3. PubMed ID: 17554705
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiretroviral rounds. Immediate ART after an OI: are we there yet?
    Grant P; Zolopa A; Landovitz RJ
    AIDS Clin Care; 2008 Sep; 20(9):74-5. PubMed ID: 18841619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.